Literature DB >> 25395150

Low Lymph Node Retrieval After Preoperative Chemoradiation for Rectal Cancer is Associated with Improved Prognosis in Patients with a Good Tumor Response.

Hun Jin Kim1, Jeong Seon Jo, Soo Young Lee, Chang Hyun Kim, Young Jin Kim, Hyeong Rok Kim.   

Abstract

PURPOSE: To examine the association between the number of lymph nodes retrieved and oncologic outcome after preoperative chemoradiation for rectal cancer according to tumor regression grade.
METHODS: Patients with rectal cancer who underwent curative surgery between May 2004 and December 2012 were analyzed retrospectively. Using multivariate analysis, the correlation between clinicopathologic variables and the number of lymph nodes retrieved was evaluated. The associations between the oncologic outcome and number of lymph nodes retrieved were also investigated according to the tumor regression grade.
RESULTS: In total, 1,332 patients were identified, of whom 433 (32.8 %) received preoperative chemoradiation. Multivariate analysis revealed that preoperative chemoradiation was an independent predictor of the number of lymph nodes retrieved (P = 0.002). After chemoradiation, the number of total and positive lymph nodes retrieved was inversely correlated with tumor regression. Retrieval of ≥12 lymph nodes was not an independent prognostic factor for disease-free survival; however, among patients with a good tumor response, those with <12 lymph nodes retrieved had a significantly better 3-year disease-free survival (P = 0.030) than those with ≥12 lymph nodes retrieved.
CONCLUSIONS: Reduced lymph node yield after preoperative chemoradiation for rectal cancer does not indicate inadequate oncologic surgery. It may represent good treatment response and better prognosis, especially in patients with good pathologic tumor regression after chemoradiation.

Entities:  

Mesh:

Year:  2014        PMID: 25395150     DOI: 10.1245/s10434-014-4235-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

1.  Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching.

Authors:  Naruhiko Ikoma; Prajnan Das; Wayne Hofstetter; Jaffer A Ajani; Jeannelyn S Estrella; Hsiang-Chun Chen; Xuemei Wang; Rashida A Callender; Cong Zhu; Christina L Roland; Keith F Fournier; Janice N Cormier; Paul Mansfield; Brian D Badgwell
Journal:  Gastric Cancer       Date:  2018-05-05       Impact factor: 7.370

2.  Association of certification, improved quality and better oncological outcomes for rectal cancer in a specialized colorectal unit.

Authors:  Annika Jacob; Wolfgang Albert; Thomas Jackisch; Christiane Jakob; Anja Sims; Helmut Witzigmann; Sören Torge Mees; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2020-11-09       Impact factor: 2.571

3.  What Is the Minimum Number of Examined Lymph Nodes After Neoadjuvant Therapy in Rectal Cancer?

Authors:  Peng Gao; Yongxi Song; Yuchong Yang; Shan Zhao; Yu Sun; Jingxu Sun; Xiaowan Chen; Zhenning Wang
Journal:  J Gastrointest Surg       Date:  2018-02-21       Impact factor: 3.452

4.  Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique.

Authors:  Naruhiko Ikoma; Jeannelyn S Estrella; Wayne L Hofstetter; Jaffer A Ajani; Keith F Fournier; Paul F Mansfield; John M Skibber; Brian D Badgwell
Journal:  J Gastrointest Surg       Date:  2018-07-27       Impact factor: 3.452

5.  Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.

Authors:  Stefan Münch; Daniel Habermehl; Ayman Agha; Claus Belka; Stephanie E Combs; Renate Eckel; Helmut Friess; Alexander Gerbes; Natascha C Nüssler; Wolfgang Schepp; Roland M Schmid; Wolfgang Schmitt; Gabriele Schubert-Fritschle; Bernhard Weber; Jens Werner; Jutta Engel
Journal:  Strahlenther Onkol       Date:  2017-10-25       Impact factor: 3.621

6.  Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram.

Authors:  Yanwu Sun; Yiyi Zhang; Zhekun Huang; Pan Chi
Journal:  J Gastrointest Surg       Date:  2018-09-05       Impact factor: 3.452

7.  Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance.

Authors:  Dedrick Kok Hong Chan; Ker-Kan Tan
Journal:  J Gastrointest Oncol       Date:  2019-02

8.  Low-tie IMA and selective D3 lymph node sampling in laparoscopic rectal resection for carcinoma rectum: comparison of surgical and oncological outcomes with the open technique.

Authors:  Radha Sadasivan Nair Sindhu; Bonny Natesh; Ramesh Rajan; Kakkat Shanavas; Geetha Sukumaran; Lekshmi Kumar Gayathri
Journal:  J Gastrointest Oncol       Date:  2017-10

9.  The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection.

Authors:  Marcin Zeman; Marek Czarnecki; Ewa Chmielik; Adam Idasiak; Władysław Skałba; Mirosław Strączyński; Piotr J Paul; Agnieszka Czarniecka
Journal:  World J Surg Oncol       Date:  2021-05-21       Impact factor: 2.754

10.  Log odds of positive lymph nodes is an excellent prognostic factor for patients with rectal cancer after neoadjuvant chemoradiotherapy.

Authors:  Tianlei Xu; Lin Zhang; Liang Yu; Yuelu Zhu; Hui Fang; Bo Chen; Haizeng Zhang
Journal:  Ann Transl Med       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.